Animal Intestinal Health Global Market Report 2024

The global animal intestinal health market has grown rapidly in recent years. It will grow from $3.69 billion in 2023 to $4.11 billion in 2024 at a compound annual growth rate (CAGR) of 11.4%. The growth observed in the historical period can be credited to initiatives aimed at reducing antibiotic usage, a rising demand for animal protein, advancements in probiotics research, regulatory encouragement for healthier alternatives, heightened consumer awareness, a growing emphasis on animal welfare, and an increasing demand for organic and natural products.

The global animal intestinal health market is expected to see rapid growth in the next few years. It will grow to $6.3 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%. The anticipated growth in the forecast period is driven by factors such as global population expansion and the heightened demand for protein, ongoing research and innovation in the field of probiotics, strengthened regulatory support, advancements in microbiome science, and the broadening of applications in aquaculture. Key trends expected during this period encompass the adoption of antibiotic alternatives, the integration of technology for monitoring purposes, technological innovations in animal nutrition, the implementation of telehealth and monitoring solutions, and the development of customized nutrition solutions.

The animal intestinal health market is poised for growth due to the increasing prevalence of intestinal disorders among livestock worldwide. These disorders impact gastrointestinal functionality in animals, affecting their performance and sustainable production. Probiotics and eubiotics are integral in preventing diseases such as anthrax, subclinical parasitism, and hemorrhagic bowel syndrome by enhancing enzymatic activity in the gastrointestinal tract. As of June 2022, official data from gov.UK indicated a notable 48% rise in animal disease-related procedures in 2021. This surge in intestinal disorders in livestock is a driving force behind the expansion of the animal intestinal health market.

The animal intestinal health market is anticipated to flourish owing to the growing prominence of livestock farming. Livestock farming, encompassing breeding and managing domesticated animals for various outputs, underscores the significance of intestinal health in optimizing animal performance, feed efficiency, and overall productivity. In 2021, Eurostat data revealed a substantial livestock population in the European Union, including millions of pigs, bovine animals, sheep, and goats. This rise in livestock farming practices is expected to serve as a catalyst for the expansion of the animal intestinal health market.

A dominant trend in the animal intestinal health market is the emergence of innovative product offerings. Key players are channeling efforts into developing cutting-edge solutions to bolster their market positions. For instance, in May 2021, CHR Hansen, a Denmark-based bioscience company, introduced Bovacillus - a probiotic product designed to support dairy and beef cattle health and performance. This versatile probiotic, comprising Bacillus licheniformis and Bacillus subtilis strains, has been cultivated from natural sources, exhibiting resilience in the harsh conditions of feed production and gastrointestinal environments. Its adaptable nature allows usage in various feed applications, from mineral mixes to milk replacers, catering to diverse needs in the industry.

Major players within the animal intestinal health market are steering their focus towards innovative solutions, exemplified by the introduction of active microbial solutions aimed at bolstering their market share and revenue streams. Active microbial solutions, concentrated suspensions of microorganisms, serve to enhance the health and productivity of plants, animals, and soil. For instance, in June 2022, Kemin Industries Inc., a US-based ingredient manufacturer dedicated to improving life quality for both humans and animals, unveiled ENTEROSURE. This product is tailored to address gut health concerns, augment animal productivity, and counteract harmful bacterial growth in poultry and cattle, while simultaneously supporting a healthy microbiome. ENTEROSURE offers a holistic approach to fortify intestinal resilience, minimizing the risks posed by diseases affecting animal intestinal health. The aim is to empower animal producers in achieving profitable, efficient, and sustainable protein production while addressing prevalent concerns linked to intestinal health.

In a strategic move, Cargill Inc., a prominent US-based company operating in the food and agriculture sectors, completed the acquisition of Delacon Biotechnik GmbH in June 2022 for an undisclosed sum. This acquisition sets the stage for Delacon's amplified potential for future advancements and an expanded global reach for phytogenic feed additives. The merger empowers Cargill to diversify its range of animal nutrition products and leverage Delacon's specialized expertise in phytogenic feed additives. Delacon Biotechnik GmbH, headquartered in Austria, specializes in offering natural feed additives for animal nutrition.

Major companies operating in the animal intestinal health market report are Koninklijke DSM N.V., Archer-Daniels-Midland Company, Kemin Industries Inc., E. I. du Pont de Nemours and Company, Cargill Incorporated, Novozymes A/S, Nutreco N.V., Chr. Hansen Holding A/S, Bluestar Adisseo Company, Dr. Eckel Animal Nutrition GmbH & Co. KG, Alltech Inc., Evonik Industries AG, Lallemand Animal Nutrition, Biorigin, AB Vista, Land O'Lakes Inc., Lesaffre, Unique Biotech, Pure Cultures LLC, Agrihealth, Arm & Hammer Animal and Food Production, BENEO GmbH, Delacon Biotechnik Ges.m.b.H., Pancosma SA, Phytobiotics Futterzusatzstoffe GmbH, Vetpharma Animal Health S.L., Vetoquinol S.A., Virbac Corporation, Wacker Chemie AG, Zoetis Inc.

Asia-Pacific was the largest region in the animal intestinal health market share in 2023. The regions covered in the animal intestinal health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the animal intestinal health market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary categories of products within the realm of animal intestinal health comprise phytogenics, probiotics, immunostimulants, and prebiotics. Phytogenics encompass plant-derived products incorporated into feed to improve feed palatability and enhance animal performance. These products can be derived from microbial or plant sources, and they are available in various forms such as dry and liquid. Their application extends across diverse livestock categories, including poultry, swine, ruminants, and aquaculture.

This report provides animal intestinal health market statistics, including animal intestinal health industry global market size, regional shares, competitors with an animal intestinal health market share, detailed animal intestinal health market segments, market trends, and opportunities, and any further data you may need to thrive in the animal intestinal health industry. This animal intestinal health market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The animal intestinal health market consists of sales of eubiotics and synbiotic products for animal gut health. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.